The invention provides a syringe for use in an ophthalmic injection. The syringe comprises a body, a stopper and a plunger. The body comprises an outlet at an outlet end and the stopper is arranged within the body such that a front surface of the stopper and the body define a variable volume chamber from which a fluid can be expelled though the outlet. The plunger comprises a plunger contact surface at a first end and a rod extends between the plunger contact surface and a rear portion. The plunger contact surface is arranged to contact the stopper but not couple thereto, such that the plunger can be used to force the stopper towards the outlet end of the body, reducing the volume of the variable volume chamber, but not to move the stopper away from the outlet end.

The present invention provides a drug delivery device (1) comprising: a drug reservoir (20) comprising a reservoir body (21) extending along a reference axis and an elastomeric stopper (30) arranged in the reservoir body (21), the elastomeric stopper (30) comprising a stopper body (31) extending between a front stopper end (32) and a rear stopper end (34) and having a plurality of axially spaced apart circumferential ribs (33) for sealing interaction with an interior wall (22) of the reservoir body (21), and a plunger rod structure (10) for displacing the elastomeric stopper (30) relative to the interior wall (22), the plunger rod structure (10) extending along the reference axis and comprising a distal end face (12, 14) adapted to interface with the rear stopper end (34). The distal end face (12, 14) comprises a first force transferring portion (14) and a second force transferring portion (12), the first force transferring portion (14) axially leading the second force transferring portion (12) and being adapted to interact with a peripheral portion of the rear stopper end (34).

A syringe is to be obtained by using PTFE for a gasket main body that makes a direct contact with an injection solution and using a slidable silicone rubber at a portion that does not make contact with the injection solution.

A syringe A includes a syringe barrel 1, a gasket 10 press-fitted within the syringe barrel 1, and a plunger rod 5 mounted in the gasket 10. In the gasket 10, a concaved groove 18 is formed over the whole circumference of a slide-contact surface 11 of a main body portion 26 that is formed of a rigid plastic having a drug solution-resistant property against a drug solution 30 to be loaded in the syringe barrel 1 and that is configured to slidingly contact an inner circumferential surface 2 of the syringe barrel 1. In a slide-contact ring 19 that is to be fitted in the concaved groove 18 and that is configured to slidingly contact the syringe barrel inner circumference surface 2, a silicone oil and a spherical ultrahigh molecular weight fine powder are added to a silicone rubber base material 19c.

A pharmaceutical container for drug delivery includes a barrel configured to slidably receive a stopper. The container exhibits a ratio of a break loose force (BLF) relative to a glide force (GF) of BLF/GF≤2 during a break loose and glide force test and a total glide force variation TGFV=GF.sub.max−GF.sub.min measured when the stopper is moved from a start position to its end position is TGFV<2 N.

A syringe for injecting solid, hard and rough granular material includes: a longitudinal injection chamber having constant section and an internal diameter of less than 4.5 mm, having a distal outlet mouth for the flow out of the material, whose surface is the same as the injection chamber, and a proximal mouth, in which granular material is inserted; a plunger sealedly mobile along the injection chamber, joined to a stem which enters the injection chamber through the proximal mouth, the plunger having: a transversal section which sealingly couples with the surface of the injection chamber, and having an operative surface, facing towards the distal mouth of the injection chamber; and a body projecting longitudinally internally of the injection chamber, fixed substantially axially to the operating surface of the plunger, having a diameter that is less than 70% of that of the injection chamber and a length greater than 6 mm.

The invention relates to a medical drug delivery apparatus which comprises a cartridge (1) being closed at one end by a membrane (12) and at the opposite end by a movable piston (15). A piston rod foot (1) is provided for transferring the pressure from the piston rod (20) of the drug delivery apparatus and onto the piston (15). The piston rod foot (1) comprises a center part (2) abutting the piston rod (20) and an outer part (3) which center part (2) and outer part (3) are coupled together such that the two (2, 3) can be moved relative to one another, yet remain coupled to each other, when a force above a certain threshold limit is applied to the outer part (3).

The present invention provides, medical rubber parts that do not physically and chemically affect the quality of preparations. The present invention relates to a medical rubber part obtained by press-molding an unvulcanized rubber mainly containing a rubber for forming a liquid-contacting portion and an unvulcanized rubber mainly containing a butyl-based rubber for forming a non-liquid-contacting portion, wherein a color difference dE between the liquid-contacting portion and the non-liquid-contacting portion is 6.0 or more in NBS units.

A slidable rubber material that has an amino-modified interfacial layer that does not affect the compression set. Although the slidable rubber material includes a rubber component such as a butyl rubber or halogenated butyl rubber etc. having the low-compression set, which contains a vulcanization agent such as a nitrogen/sulfur compound or a vulcanizing auxiliary agent, the rubber part is coated with a silicone rubber layer. The slidable rubber material exhibits a slidability and resists the detachment or elution of fine particles from the coating layer. A rubber component and a vulcanization agent; an interfacial modification layer that coats the rubber part and an amino-modified silicone compound is incorporated with surface molecules of the rubber part; and a layer that coats the interfacial modification and contains solid fine particles, an addition-type or condensation-type silicone rubber in which the particles are dispersed, and a curing catalyst for silicone rubber.

A cylinder-piston unit of a needle-free injector, with at least one cylinder accommodating an injection solution, at least one piston, and an adhesive coating arranged in the area of the free end face of the cylinder. The cylinder has a bottom portion, on which a discharge tube is arranged. An adhesive disc, which is displaceable in the direction of the center line of the cylinder-piston unit between an installation position and an application position, is arranged on the discharge tube and/or on the bottom portion. The adhesive disc has an adhesive coating on each of the two end faces. In the installation position, the discharge tube can be sealed off in the adhesive disc. In the application position, the front edge of the discharge nozzle lies in the plane of the front adhesive coating or protrudes beyond this plane by at least 0.5 mm. A needle-free cylinder-piston unit of an injector whose discharge system is suitable for safely penetrating the outer layers of skin, covered by the term “dermis”, in order to convey the injection solution into or under the skin.

The invention relates to a medical injection device comprising a container body (1) and a stopper (2) in gliding engagement within the container body (1) for expelling a fluid (3) through an opening of said container body (1), wherein: —at least the distal portion (20) of the stopper (2) that is in contact with the fluid (3) is made of a thermoplastic polyolefin, —the stopper (2) further comprises at least one O-ring (4, 4′) maintained in at least one peripheral groove (210, 210′), —said O-ring (4, 4′) is made of a butyl-type rubber; and —the cross-section of said peripheral groove (210, 210′) is designed so as to compress both axially and radially the O-ring (4) when said O-ring (4) is engaged in the peripheral groove (210) between the stopper (2) and the inner wall (10) of the container body (1).